Konapharma Ltd. is a Swiss CMO (Contract Manufacturing Organization) specializing in the production of solid dosage forms, including "difficult to produce" MUPS (Multi unit pellet systems) tablets and other retard forms, as well as bi-layered tablets. The company also possesses a special permit to handle and process controlled substances such as narcotics. With a total floor area of 15,570 m2, Konapharma Ltd. operates two bulk production units and two primary and secondary packaging units on the same site. Their services include high volume blistering, specialized packaging for inhalation capsules and vials, and hard gelatin capsule filling with 100% control. Founded in 1989, Konapharma Ltd. operates in the Manufacturing and Pharmaceutical industries. As of now, there is no record of last investment or associated investors.
There is no investment information
No recent news or press coverage available for Konapharma Ltd..
,-Ltd.-logo.jpg){kind=logo}
We care about your data, and we'd love to use cookies make your experience better.
